Tosk, Inc. Company Profile

04:29 EST 12th December 2018 | BioPortfolio

News Articles [2 Associated News Articles listed on BioPortfolio]

Deals this week: AzurRx BioPharma, Innovent Biologics, Tosk

AzurRx BioPharma plans to raise $50m through a public offering of securities. The company intends to issue the securities periodically in...Read More... The post Deals this week: AzurRx BioPharma, In...

Tosk Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 24072018] Prices from USD $250

SummaryTosk Inc Tosk is a drug developing company that provides development of safety and efficacy conditions of drugs. The company discovers and develops new drugs for cancer and other conditions usi...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [3 Associated Companies listed on BioPortfolio]

Tosk Inc.

Tosk was founded in 1998 to discover new drugs for genetic diseases and cancer. The original technology, in part licensed from Stanford University,StealthGene and Targeted Gene Delivery technologies. ...

Tosk, Inc.

Tosk Incorporated

Neurodegenerative diseases and cancer. The Company’s AON QTS technology not only targets the neurodegeneration process, which will allow discovered drugs to be applicable to a variety of AON disease...

More Information about "Tosk, Inc." on BioPortfolio

We have published hundreds of Tosk, Inc. news stories on BioPortfolio along with dozens of Tosk, Inc. Clinical Trials and PubMed Articles about Tosk, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Tosk, Inc. Companies in our database. You can also find out about relevant Tosk, Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record